Omnia Medical

Omnia Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.8M

Overview

Omnia Medical is a U.S.-based orthopedic implant company focused on spine and pain intervention, with a commercial portfolio of FDA-cleared devices. The company emphasizes engineering-driven innovation to create reproducible instrumentation for surgeons, targeting improved patient outcomes and cost savings for healthcare systems. Recent milestones include the 2025 FDA clearance and commercial launch of its PsiF DNA SI Joint Stabilization System and the resolution of significant litigation with a competitor. Omnia operates with a direct sales and distributor model, seeking to expand its commercial footprint in the competitive spine device market.

Orthopedic SpineInterventional PainMusculoskeletal

Technology Platform

Engineering-driven design of reproducible spinal implant systems and surgical instrumentation, focusing on biomechanics and workflow efficiency.

Funding History

1
Total raised:$1.8M
Seed$1.8M

Opportunities

The growing, underserved market for SI joint pain treatment and the constant demand for spine fusion procedures with improved efficiency present significant commercial opportunities.
Omnia's focus on reducing operative time and cost aligns perfectly with healthcare's value-based care trends, potentially driving hospital adoption.

Risk Factors

Intense competition from large, established medical device companies and the constant need for costly sales and marketing efforts pose significant market risks.
The company also remains subject to regulatory risks for new product clearances and the ongoing challenge of protecting its intellectual property in a litigious industry.

Competitive Landscape

Omnia competes in the crowded spinal implant market against giants like Medtronic, Stryker, and Johnson & Johnson's DePuy Synthes, as well as pure-play spine companies like NuVasive, Globus Medical, and SeaSpine. In the SI joint niche, it faces competitors like SI-BONE, Medtronic (with the IFuse system), and other smaller firms, making differentiation through product design and surgeon relationships critical.